InflaRx N.V.

IFRXNASDAQHealthcare● Active

$1.71

$-0.13(-7.07%)

Market Cap$123519376

P/E Ratio—

52W High$2.949

52W Low$0.741

Avg Volume1.6M

Open$1.86

Beta2.44

Employees Ownership Insider Trades

InflaRx N.V. (IFRX) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · IFRX · as of Mar 20, 2026

Latest filing snapshot

-9-12.16%vs prior year

InflaRx N.V. (IFRX) employee data is sourced from the annual SEC 20-F filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 20-F·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

-9

Growth % (1Y)

-12.16%

Revenue / Employee

$451

Net Income / Employee

$-702.1K

Market Cap

$124M

IFRX Employee Count

2017 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-20	2025-12-31	65	-9	-12.16%
2025-03-20	2024-12-31	74	+8	+12.12%
2024-03-21	2023-12-31	66	+18	+37.50%
2023-03-22	2022-12-31	48	-11	-18.64%
2022-03-24	2021-12-31	59	+10	+20.41%
2021-03-25	2020-12-31	49	+4	+8.89%
2020-04-29	2019-12-31	45	+7	+18.42%
2019-03-28	2018-12-31	38	+17	+80.95%
2018-03-29	2017-12-31	21	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

ARTV

Artiva Biotherapeutics, Inc.

Connect Biopharma Holdings Limited

KLRS

Kalaris Therapeutics Inc

14$78M

CNTX

Context Therapeutics Inc.

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · IFRX peer comparison

About IFRX employees

IFRX Employees · Headcount

InflaRx N.V. (IFRX) employee data is sourced from the annual SEC 20-F filing. As of 2025, InflaRx N.V. had 65 full-time employees globally. Full-time employees only. Global consolidated headcount.

InflaRx N.V. employs 65 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $451, reflecting the company's operational efficiency.

InflaRx N.V.'s workforce decreased by 9 (12.16%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

InflaRx N.V.'s revenue per employee of $451 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

IFRX Employees · 5 questions

As of the latest SEC 20-F filing (2025), InflaRx N.V. had 65 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

InflaRx N.V. employee counthow many employees does InflaRx N.V. haveIFRX total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-20